跳至主要内容
临床试验/NCT02377440
NCT02377440已完成不适用

Effects of Angiotensin Converting Enzyme Inhibitors (ACEI) on Bone Turnover

The University of Texas Health Science Center, Houston2 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2013年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
32
试验地点
2
主要终点
Change in serum CTX levels in pg/mL

研究概览

简要总结

The investigators hypothesize that older persons (≥45 years) treated with ACEI for HTN control will have: i) improved status of bone turnover (decreased P1NP and CTX), and ii) decreased levels of RANKL and RANKL/OPG, compared to those not treated with ACEI and not using RAS-related medications

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
45 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • at least 45 years of age
  • a diagnosis of (either new or uncontrolled) HTN who will need a new medication for HTN control
  • able to consent (no medial issues impairing judgment for consenting based on clinical providers' judgment).

排除标准

  • younger than 45 years of age
  • a diagnosis of metabolic bone disease
  • a diagnosis of osteoporosis or use of medication to treat osteoporosis
  • a diagnosis of diabetes mellitus, or renal insufficiency, or cancer
  • history of allergy to ACEI or ARB, 6) history of use of ACEI or ARB.

结局指标

主要结局

Change in serum CTX levels in pg/mL

时间窗: baseline, 3 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nahid Rianon

Assistant Professor

The University of Texas Health Science Center, Houston

研究点 (2)

Loading locations...

相似试验

Effects of ACEI on Bone Turnover | 临床试验